Pricing Log in Create free account

Greenwich LifeSciences, Inc. (GLSI) vs Sol-Gel Technologies Ltd. (SLGL)

Greenwich LifeSciences, Inc. and Sol-Gel Technologies Ltd. are both Biotechnology companies. Greenwich LifeSciences, Inc. is the larger, with a market value of $222.7M against $199.8M — 1.1× the size. Greenwich LifeSciences, Inc. has the higher net margin (0.00% vs −910.1%) and the higher return on invested capital (0.00% vs −6,630.2%). Across the 13 metrics below, Sol-Gel Technologies Ltd. leads on 7 and Greenwich LifeSciences, Inc. on 6.

Valuation

Metric GLSI SLGL Biotechnology median
P/E n/m n/m 10.60
P/S n/m 111.18 9.40
P/B 71.16 4.15 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 120.87 9.02
Earnings yield (9.95%) (9.24%) (32.88%)
Free cash flow yield (5.63%) (10.66%) (23.13%)

Profitability

Metric GLSI SLGL Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (986.96%) 0.00%
Net margin 0.00% (910.14%) 0.00%
Free cash flow margin 0.00% (1,185.18%) 0.00%
Return on equity (986.31%) (40.85%) (51.96%)
Return on assets (374.46%) (35.11%) (46.06%)
Return on invested capital 0.00% (6,630.24%) 0.00%

Growth

Metric GLSI SLGL Biotechnology median
Revenue growth (TTM) — (92.50%) 6.76%
EPS growth (last fiscal year) (6.72%) 42.37% 29.88%
Revenue growth, 5-year CAGR — 17.19% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GLSI SLGL Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.54 10.37 4.97
Net debt to EBITDA 0.32 3.23 1.01

Dividend

Metric GLSI SLGL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GLSI SLGL Biotechnology median
Market cap 222.67m 199.75m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack